Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Areva-Societe Des Participations Du Commissariat A Lenerg (OTC: ARVCF).

Full DD Report for ARVCF

You must become a subscriber to view this report.

Recent News from (OTC: ARVCF)

Reuters: Few foreign bids expected for $1B Petrobras gas project
Brazil was hoping to attract competition among global players to build a $1B natural gas plant, but only around five of the 30 foreign companies invited by Petrobras ( PBR -0.8% ) bid on the new processing plant likely will submit bids by the Aug. 28 deadline, Reuters reports. More new...
Source: SeekingAlpha
Date: August, 21 2017 10:59
Books will close today August 21st, 2017.
Books will close today August 21st, 2017.
Source: OTC Markets
Date: August, 21 2017 00:00
NexGen Energy to become one of the biggest uranium producers in the World - Unless it gets acquired first
NexGen Energy (NXE) released results of the long awaited PEA for its world-class Arrow uranium project. The results definitely haven't disappointed. The Arrow mine is expected to produce 18.5 million lb uranium per year over an initial 14.4-year mine life. Over the first five years, the ave...
Source: SeekingAlpha
Date: August, 03 2017 12:55
Areva-Societe Des Participations Du Commissariat A Lenerg reports 1H results
Areva-Societe Des Participations Du Commissariat A Lenerg ( OTCPK:ARVCF ): 1H net loss of €313M More news on: Areva-Societe Des Participations Du Commissariat A Lenerg, Earnings news and commentary, Energy stocks news, Read more ...
Source: SeekingAlpha
Date: July, 28 2017 01:57
Reuters: EDF's plan to acquire Areva stake to be approved by EU regulators
Electricite de France ( OTC:ECIFF , OTCPK:ECIFY ) is set to gain unconditional approval from the EU competition authorities for its plan to acquire a controlling stake in ailing Areva's ( OTCPK:ARVCF ) nuclear reactor business, Reuters reports. More news on: Electricite de France SA, El...
Source: SeekingAlpha
Date: May, 19 2017 18:15
Resource Sector Digest: A Dog's Breakfast
The GDXJ has become a dog's breakfast, and it's about to get worse. This is the latest edition of Resource Sector Digest . ( Vol. 85 - September 24, 2017 ) Brought to you by Itinerant and The Investment Doctor . In this edition we shall: set the scene, highlight actionable id...
Source: SeekingAlpha
Date: April, 25 2017 05:00
Uranium Spot Might Hit $51-$54 In 2018
Natural uranium, or triuranium octoxide (U3O8), prices have soared to $138 per pound in mid-2007 and plunged to $18 per pound December of 2016. Now it is about $25 per pound. Uranium, which is 84.8% of triuranium octoxide, follows closely to the price of natural uranium. The March 11, 2011 Jap...
Source: SeekingAlpha
Date: March, 14 2017 18:12
EU approves Areva restructuring plan
The European Union approves a restructuring plan for French nuclear firm Areva ( OTCPK:ARVCF ), saying a planned €4.5B ($4.76B) capital injection would not unduly distort competition. More news on: Areva-Societe Des Participations Du Commissariat A Lenerg, Energy stocks news, ...
Source: SeekingAlpha
Date: January, 10 2017 10:51
Trump Goes Nuclear On Nuclear
Nuclear energy remains, despite lingering concerns over safety and radioactive hazards, the most reliable, zero-emission energy source available today. It has, however, fallen out of vogue, owing in large part to the dramatic fall in the price of natural gas and other renewables as well as the...
Source: SeekingAlpha
Date: December, 29 2016 14:55
EDF to buy up to 75% stake in Areva's nuclear reactor unit
Eléctricité de France ( OTC:ECIFF ) agrees to buy Areva's ( OTCPK:ARVCF ) nuclear reactor unit as part of a €8B package reached earlier this year to rescue Areva after five consecutive years of losses. More news on: Electricite de France SA, Areva-Societe Des Participati...
Source: SeekingAlpha
Date: November, 16 2016 08:08


About Areva-Societe Des Participations Du Commissariat A Lenerg (OTC: ARVCF)

Logo for Areva-Societe Des Participations Du Commissariat A Lenerg (OTC: ARVCF)

AREVA supplies advanced technology solutions for power generation with less carbon. Its expertise and unwavering insistence on safety, security, transparency and ethics are setting the standard, and its responsible development is anchored in a process of continuous improvement.




Current Management

  • Anne Lauvergeon / CEO
  • P. Braidy / CFO
  • B. Loubert / Secretary

Current Share Structure

  • Market Cap: $1,992,665,480 - 03/16/2018
  • Issue and Outstanding: 383,204,900 - 05/27/2011


Daily Technical Chart for (OTC: ARVCF)

Daily Technical Chart for (OTC: ARVCF)

Stay tuned for daily updates and more on (OTC: ARVCF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ARVCF)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

OTC Report



Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ARVCF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of ARVCF and does not buy, sell, or trade any shares of ARVCF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: